The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter Study.

IF 2.3 Q3 ONCOLOGY Prostate Cancer Pub Date : 2021-04-21 eCollection Date: 2021-01-01 DOI:10.1155/2021/5539851
Mohammed Jayed Alenzi, Amany A Ghazy, Diaa-Eldin Taha
{"title":"The Weight of HLA-DPA1 rs3077 Single Nucleotide Polymorphism in Prostate Cancer, a Multicenter Study.","authors":"Mohammed Jayed Alenzi,&nbsp;Amany A Ghazy,&nbsp;Diaa-Eldin Taha","doi":"10.1155/2021/5539851","DOIUrl":null,"url":null,"abstract":"<p><p>Prostate cancer (PCa) has almost the highest genetic transmission that mimics an autosomal dominance hereditary pattern of cancers in some families. Its incidence in Arab countries was reported to be steadily increasing. <i>Aim</i>. To determine the relevance of HLA-DPA1 rs3077 (A/G) SNP with prostate cancer's risk and/or severity. <i>Subjects and Methods</i>. Forty PCa patients and forty age matched patients with benign prostatic hyperplasia (BPH), as a control group, were enrolled in the study. Serum levels of urea, creatinine, total prostate-specific antigen (PSA), and free PSA were measured. PSA ratio was determined as well. Genotyping of HLA-DPA1 rs3077 (A/G) SNP was done using real-time PCR. <i>Results</i>. The measured lab parameters, except free PSA, were significantly higher among PCa patients in comparison to controls (<i>P</i> < 0.001 <sup><i>∗</i></sup> ). Moreover, PSA ratio was significantly high among PCa patients (<i>P</i> < 0.001 <sup><i>∗</i></sup> ). HLA-DPA1 rs3077 GG genotype was more frequent in PCa patients and the associated OR was 2.546 (<i>P</i>=0.059), while AA genotype was more frequent in the control group and the associated OR was 0.145 (<i>P</i>=0.081). Frequency of G allele was higher among PCa patients than the control group while A allele frequency was significantly decreased (<i>P</i>=0.034 <sup><i>∗</i></sup> ) (protective allele). On multivariate analysis, there is no significant correlation found between HLA-DPA1 rs3077 SNP and PSA ratio (OR = 4.5, 95% CI = 1.2-17.4, <i>P</i>=0.856). <i>Conclusion</i>. HLA-DPA1 rs3077 G allele could be a risk factor for prostate cancer. However, HLA-DPA1 rs3077 SNP has no relation to PCa severity.</p>","PeriodicalId":20907,"journal":{"name":"Prostate Cancer","volume":"2021 ","pages":"5539851"},"PeriodicalIF":2.3000,"publicationDate":"2021-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084672/pdf/","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prostate Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2021/5539851","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 4

Abstract

Prostate cancer (PCa) has almost the highest genetic transmission that mimics an autosomal dominance hereditary pattern of cancers in some families. Its incidence in Arab countries was reported to be steadily increasing. Aim. To determine the relevance of HLA-DPA1 rs3077 (A/G) SNP with prostate cancer's risk and/or severity. Subjects and Methods. Forty PCa patients and forty age matched patients with benign prostatic hyperplasia (BPH), as a control group, were enrolled in the study. Serum levels of urea, creatinine, total prostate-specific antigen (PSA), and free PSA were measured. PSA ratio was determined as well. Genotyping of HLA-DPA1 rs3077 (A/G) SNP was done using real-time PCR. Results. The measured lab parameters, except free PSA, were significantly higher among PCa patients in comparison to controls (P < 0.001 ). Moreover, PSA ratio was significantly high among PCa patients (P < 0.001 ). HLA-DPA1 rs3077 GG genotype was more frequent in PCa patients and the associated OR was 2.546 (P=0.059), while AA genotype was more frequent in the control group and the associated OR was 0.145 (P=0.081). Frequency of G allele was higher among PCa patients than the control group while A allele frequency was significantly decreased (P=0.034 ) (protective allele). On multivariate analysis, there is no significant correlation found between HLA-DPA1 rs3077 SNP and PSA ratio (OR = 4.5, 95% CI = 1.2-17.4, P=0.856). Conclusion. HLA-DPA1 rs3077 G allele could be a risk factor for prostate cancer. However, HLA-DPA1 rs3077 SNP has no relation to PCa severity.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多中心研究HLA-DPA1 rs3077单核苷酸多态性在前列腺癌中的分量
前列腺癌(PCa)几乎具有最高的遗传传递,在一些家庭中模仿癌症的常染色体显性遗传模式。据报道,其在阿拉伯国家的发病率正在稳步上升。的目标。确定HLA-DPA1 rs3077 (A/G) SNP与前列腺癌风险和/或严重程度的相关性。研究对象和方法。选取40例PCa患者和40例年龄匹配的良性前列腺增生(BPH)患者作为对照组。测定血清尿素、肌酐、总前列腺特异性抗原(PSA)和游离PSA水平。测定PSA比值。采用实时荧光定量PCR对HLA-DPA1 rs3077 (A/G) SNP进行基因分型。结果。除游离PSA外,PCa患者的实验室测量参数均显著高于对照组(P < 0.001 *)。此外,前列腺癌患者的PSA比率显著升高(P < 0.001 *)。HLA-DPA1 rs3077 GG基因型在PCa患者中多见,OR为2.546 (P=0.059),而AA基因型在对照组中多见,OR为0.145 (P=0.081)。前列腺癌患者的G等位基因频率高于对照组,而保护性等位基因A的频率显著降低(P=0.034 *)。多因素分析显示HLA-DPA1 rs3077 SNP与PSA比值无显著相关(OR = 4.5, 95% CI = 1.2 ~ 17.4, P=0.856)。结论。HLA-DPA1 rs3077g等位基因可能是前列腺癌的危险因素。然而,HLA-DPA1 rs3077 SNP与PCa严重程度无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Prostate Cancer
Prostate Cancer ONCOLOGY-
CiteScore
2.70
自引率
0.00%
发文量
9
审稿时长
13 weeks
期刊介绍: Prostate Cancer is a peer-reviewed, Open Access journal that provides a multidisciplinary platform for scientists, surgeons, oncologists and clinicians working on prostate cancer. The journal publishes original research articles, review articles, and clinical studies related to the diagnosis, surgery, radiotherapy, drug discovery and medical management of the disease.
期刊最新文献
Investigating the Relationship of G-137C, C-607A, and A-1447G Polymorphisms in the Promoter of IL-18 and CXCL10 Inflammatory Genes with Prostate Cancer in an Iranian Population. Evaluation of Second-Line Treatment for Castration-Resistant Prostate Cancer following the Administration of Upfront Androgen Receptor Signaling Inhibitors. Health-Related and Psychosocial Factors Associated with Prostate Cancer Stage at Diagnosis among Males Participating in Alberta’s Tomorrow Project Cognitive Dysfunction in Patients Treated with Androgen Deprivation Therapy: A Multimodality Functional Imaging Study to Evaluate Neuroinflammation. Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1